Adopting orphan drugs--two dozen years of treating rare diseases

N Engl J Med. 2006 Feb 2;354(5):445-7. doi: 10.1056/NEJMp058317.

Author

Marlene E Haffner¹

Affiliation

¹ Office of Orphan Products Development at the Food and Drug Administration, Rockville, Md, USA.

PMID: 16452556
DOI: 10.1056/NEJMp058317

No abstract available

Publication types

Comment
Historical Article

MeSH terms

Botulism / drug therapy
Clinical Trials as Topic
Drug Approval
Drug Industry
History, 20th Century
Humans
Immunoglobulins / therapeutic use
Immunoglobulins, Intravenous / therapeutic use
Orphan Drug Production / history
Orphan Drug Production / legislation & jurisprudence*
Rare Diseases / drug therapy*
Rare Diseases / history
United States
United States Food and Drug Administration

Substances

Immunoglobulins
Immunoglobulins, Intravenous
botulism immune globulin